Ligand validation:3IVX

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3IVX_EDO_B_503	93%	74%	0.084	0.978	0.31	0.7	-	-	0	0	100%	1
3IVX_EDO_A_532	76%	72%	0.133	0.969	0.44	0.63	-	-	0	0	100%	1
3IVX_EDO_A_533	56%	71%	0.117	0.887	0.53	0.57	-	-	0	0	100%	1
3IVX_EDO_A_507	53%	78%	0.157	0.919	0.37	0.53	-	-	3	0	100%	1
3IVX_EDO_A_508	52%	72%	0.128	0.883	0.57	0.5	-	-	0	0	100%	1
3IUB_EDO_A_694	92%	75%	0.056	0.946	0.42	0.57	-	-	0	0	100%	1
4FZJ_EDO_B_404	91%	65%	0.093	0.98	0.36	0.98	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.